litlas
ログインアカウント作成

Daniel L. Clarke‐Pearson

1983–2024 年に発表

65
論文数
43,557
被引用数
61
h 指数
64
i10 指数

被引用数

Daniel L. Clarke‐Pearson の年別被引用数1977 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 4 件1987 年: 被引用 2 件1988 年: 被引用 4 件1989 年: 被引用 4 件1990 年: 被引用 6 件1991 年: 被引用 19 件1992 年: 被引用 54 件1993 年: 被引用 63 件1994 年: 被引用 54 件1995 年: 被引用 45 件1996 年: 被引用 46 件1997 年: 被引用 72 件1998 年: 被引用 74 件1999 年: 被引用 91 件2000 年: 被引用 160 件2001 年: 被引用 145 件2002 年: 被引用 141 件2003 年: 被引用 183 件2004 年: 被引用 219 件2005 年: 被引用 234 件2006 年: 被引用 281 件2007 年: 被引用 293 件2008 年: 被引用 252 件2009 年: 被引用 289 件2010 年: 被引用 305 件2011 年: 被引用 320 件2012 年: 被引用 383 件2013 年: 被引用 331 件2014 年: 被引用 273 件2015 年: 被引用 328 件2016 年: 被引用 303 件2017 年: 被引用 276 件2018 年: 被引用 335 件2019 年: 被引用 1,184 件2020 年: 被引用 1,148 件2021 年: 被引用 1,150 件2022 年: 被引用 866 件2023 年: 被引用 541 件2024 年: 被引用 932 件2025 年: 被引用 390 件2026 年: 被引用 43 件1978〜1983 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,705 件、この内訳の 26.3%中国: 引用元論文 1,659 件、この内訳の 9.3%イギリス: 引用元論文 1,177 件、この内訳の 6.6%ドイツ: 引用元論文 876 件、この内訳の 4.9%イタリア: 引用元論文 813 件、この内訳の 4.5%カナダ: 引用元論文 766 件、この内訳の 4.3%韓国: 引用元論文 629 件、この内訳の 3.5%日本: 引用元論文 619 件、この内訳の 3.5%オランダ: 引用元論文 611 件、この内訳の 3.4%フランス: 引用元論文 593 件、この内訳の 3.3%スペイン: 引用元論文 431 件、この内訳の 2.4%オーストラリア: 引用元論文 403 件、この内訳の 2.3%
0%26.3%その他 25.7%

機関

分野

  • Medicine77%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Computer Science4.7%
  • Neuroscience1.4%
  • Engineering1.1%
  • Immunology and Microbiology1.1%
  • その他6.4%

トピック

  • Ovarian cancer diagnosis and treatment4%
  • Endometrial and Cervical Cancer Treatments3.3%
  • Radiomics and Machine Learning in Medical Imaging2.2%
  • Sepsis Diagnosis and Treatment1.9%
  • AI in cancer detection1.3%
  • Intraperitoneal and Appendiceal Malignancies1.2%
  • その他86.1%

共著者

全論文

検索で開く
  1. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach

    著者: Elizabeth R. DeLong, David M. DeLong, Daniel L. Clarke‐Pearson - Biometrics 1988 被引用: 22,316

  2. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

    著者: Peter G. Rose, Brian N. Bundy, E. Blake Watkins, J.T. Thigpen, Günther Deppe, Mitchell Maiman, Daniel L. Clarke‐Pearson, Sam J. Insalaco - New England Journal of Medicine 1999 被引用: 2,671

  3. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

    著者: Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen - Journal of Clinical Oncology 2003 被引用: 2,055

  4. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

    著者: William P. McGuire, William J. Hoskins, Mark F. Brady, Paul R. Kucera, Edward E. Partridge, Katherine Y. Look, Daniel L. Clarke‐Pearson, Martin Davidson - New England Journal of Medicine 1996 被引用: 2,872

  5. Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study

    著者: Charles W. Whitney, William T. Sause, Brian N. Bundy, John H. Malfetano, Edward V. Hannigan, Wesley C. Fowler, Daniel L. Clarke‐Pearson, Shu‐Yuan Liao - Journal of Clinical Oncology 1999 被引用: 1,537

  6. Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

    著者: Michael A. Bookman, Kathleen M. Darcy, Daniel L. Clarke‐Pearson, Richard A. Boothby, Ira Horowitz - Journal of Clinical Oncology 2003 被引用: 613

  7. Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

    著者: David S. Alberts, P. Y. Liu, Edward V. Hannigan, Robert V. O’Toole, Stephen D. Williams, James A. Young, Ernest W. Franklin, Daniel L. Clarke‐Pearson, Vinay K. Malviya, Brent DuBeshter, Mark Adelson, William J. Hoskins - New England Journal of Medicine 1996 被引用: 1,238

  8. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

    著者: Andrew Berchuck, Ayman H. Kamel, Regina S. Whitaker, B. J. Kerns, George J. Olt, R. B. Kinney, John T. Soper, R K Dodge, Daniel L. Clarke‐Pearson, Paula J. Marks - 1990 被引用: 765

  9. Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

    著者: Janiel M. Cragun, Laura J. Havrilesky, Brian Calingaert, Ingrid S. Synan, Angeles Alvarez Secord, John T. Soper, Daniel L. Clarke‐Pearson, Andrew Berchuck - Journal of Clinical Oncology 2005 被引用: 443

  10. Long-Term Follow-Up of a Randomized Trial Comparing Concurrent Single Agent Cisplatin, Cisplatin-Based Combination Chemotherapy, or Hydroxyurea During Pelvic Irradiation for Locally Advanced Cervical Cancer: A Gynecologic Oncology Group Study

    著者: Peter G. Rose, Shamshad Ali, E. Blake Watkins, J.T. Thigpen, Gunter Deppe, Daniel L. Clarke‐Pearson, Samuel J. Insalaco - Journal of Clinical Oncology 2007 被引用: 283

  11. Screening for Ovarian Cancer

    著者: Daniel L. Clarke‐Pearson - New England Journal of Medicine 2009 被引用: 402

  12. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

    著者: Gary H. Lyman, Alok A. Khorana, Anna Falanga, Daniel L. Clarke‐Pearson, Christopher R. Flowers, Mohammad Jahanzeb, Ajay K. Kakkar, Nicole M. Kuderer, Mark N. Levine, Howard A. Liebman, David S. Mendelson, Gary E. Raskob, Mark R. Somerfield, Paul A. Thodiyil, David Trent, Charles W. Francis - Journal of Clinical Oncology 2007 被引用: 952

  13. Complications of Hysterectomy

    著者: Daniel L. Clarke‐Pearson, Elizabeth J. Geller - Obstetrics and Gynecology 2013 被引用: 328

  14. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

    著者: Joan L. Walker, Deborah K. Armstrong, Helen Huang, Jeffrey Fowler, Kenneth Webster, Robert A. Burger, Daniel L. Clarke‐Pearson - Gynecologic Oncology 2005 被引用: 322

  15. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

    著者: G Omura, J A Blessing, Luis Vaccarello, M L Berman, Daniel L. Clarke‐Pearson, David G. Mutch, Blaire Anderson - Journal of Clinical Oncology 1997 被引用: 275

  16. Epidemiologic and Surgicopathologic Findings of Papillary Serous and Clear Cell Endometrial Cancers When Compared to Endometrioid Carcinoma

    著者: Frank D. Cirisano, Stanley J. Robboy, Richard K. Dodge, Rex C. Bentley, Hannah R. Krigman, Ingrid S. Synan, John T. Soper, Daniel L. Clarke‐Pearson - Gynecologic Oncology 1999 被引用: 202

  17. Pelvic exenteration: Factors associated with major surgical morbidity

    著者: John T. Soper, Andrew Berchuck, William T. Creasman, Daniel L. Clarke‐Pearson - Gynecologic Oncology 1989 被引用: 131

  18. Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma

    著者: Peter G. Rose, Stacy Nerenstone, Mark F. Brady, Daniel L. Clarke‐Pearson, George J. Olt, Stephen C. Rubin, David H. Moore, James M. Small - New England Journal of Medicine 2004 被引用: 399

  19. Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer

    著者: Robert Woolas, Feng Xu, I. J. Jacabs, Yanhong Yu, L. Daly, Andrew Brechuck, John T. Soper, Daniel L. Clarke‐Pearson, David Oram, Robert C. Bast - JNCI Journal of the National Cancer Institute 1993 被引用: 195

  20. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer

    著者: Andrew P. Soisson, John T. Soper, Daniel L. Clarke‐Pearson, Andrew Berchuck, Gustavo S. Montana, William T. Creasman - Gynecologic Oncology 1990 被引用: 157

  21. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis

    著者: Matthew T. Siedhoff, Stephanie B. Wheeler, Sarah E. Rutstein, Elizabeth J. Geller, Kemi M. Doll, Jennifer M. Wu, Daniel L. Clarke‐Pearson - American Journal of Obstetrics and Gynecology 2015 被引用: 104

  22. Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence

    著者: Andrew Nicolaides, Jawed Fareed, Alex C Spyropoulos, Rt Horn Lord Kakkar, Pier Luigi Antignani, Efthymios D. Avgerinos, Niels Bækgaard, Emma L. Barber, Ruth L. Bush, Joseph A. Caprini, Daniel L. Clarke‐Pearson, Patrick Van Dreden, I. Elalami, Grigoris Gerotziafas, Harry Gibbs, Samuel Z. Goldhaber, Stavros K. Kakkos, Elmira Lefkou, Nicos Labropoulos, Renato D. Lópes, Armando Mansilha, Chryssa Papageorgiou, Paolo Prandoni, Eduardo Ramacciotti, Carla Rognoni, Tomasz Urbanek, Jeanine M. Walenga - International Angiology 2024 被引用: 52

  23. Surgical training in gynecologic oncology: Past, present, future

    著者: Mitchel S. Hoffman, S. Dennis, Daniel L. Clarke‐Pearson, William A. Cliby, William T. Creasman, Paul B. Underwood - Gynecologic Oncology 2020 被引用: 29

  24. Overexpression and mutation of p53 in epithelial ovarian cancer.

    著者: Jeffrey R. Marks, A M Davidoff, B. J. Kerns, Peter A. Humphrey, Jeffrey C. Pence, R K Dodge, Daniel L. Clarke‐Pearson, J. Dirk Iglehart, Robert C. Bast, Andrew Berchuck - 1991 被引用: 471